SCLX
NASDAQ · Pharmaceuticals
Scilex Holding Co
$6.97
-0.50 (-6.69%)
Open$7.21
Previous Close$7.47
Day High$7.33
Day Low$6.79
52W High$34.27
52W Low$4.20
Volume—
Avg Volume112.6K
Market Cap63.43M
P/E Ratio—
EPS$-35.63
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+452.8% upside
Current
$6.97
$6.97
Target
$38.53
$38.53
$25.32
$38.53 avg
$55.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 26.07M | 28.14M | 16.86M |
| Net Income | -309,176,791 | -300,301,221 | 3.00M |
| Profit Margin | -1,185.8% | -1,126.5% | 17.8% |
| EBITDA | -300,782,571 | -308,378,418 | 6.50M |
| Free Cash Flow | — | — | 2.15M |
| Rev Growth | -7.3% | -7.3% | +5.1% |
| Debt/Equity | — | — | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |